Do I need a prescription for Arginine 2g/5ml oral solution?

Arginine 2g/5ml oral solution is classified as a Valid as a prescribable product in the UK. However, always consult a pharmacist or doctor before use. (Source: NHS dm+d)

What are the brand names for Arginine 2g/5ml oral solution?

Arginine 2g/5ml oral solution is the generic name. It is available under brand names including: Arginine 2g/5ml oral solution. (Source: NHS dm+d — Actual Medicinal Products)

Arginine 2g/5ml oral solution

Prescription only

Requires a prescription from a doctor or prescriber

Oral solution

2g/5ml

Oral

An essential amino acid that is physiologically active in the L-form.

Active ingredients:

Arginine

BNF classificationBrowse formulary

Where this medicine sits in the British National Formulary — the UK's standard prescribing reference

BNF 09.11.01

ATC classificationBrowse ATC index

International classification by the WHO, grouping medicines by the organ system they act on

A05BA01

WHO Anatomical Therapeutic Chemical code

Chemical classBrowse classes

Classification based on the molecule's chemical structure and properties

Check interactions for Arginine

No active safety alerts

Official documents, adverse reaction reporting, and safety monitoring

Report a side effect

Submit a Yellow Card report to the MHRA

Official medicine documents

Yellow Card

Report side effects (MHRA)

Drug safety updates

MHRA alerts for Arginine

Source: MHRA Products DatabaseOGL 3.0

Updated 3 months ago(16 Jan 2026)

Safety monitoring data

Yellow Card reports

MHRA

The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.

View Drug Analysis Profile

Suspected adverse reactions reported for Arginine

Browse all iDAP reports

Interactive Drug Analysis Profiles for all medicines

Report a side effect

Submit a Yellow Card report to the MHRA

Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.

EudraVigilance

EMA

The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.

Search EudraVigilance database

Browse substances A–Z in the European adverse reaction database

About EudraVigilance

Learn about EU pharmacovigilance and safety monitoring

EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.

1 branded products available

1 productsShow details

1 products

Possibly available on the UK marketRestricted supplyDiscontinuedAvailability per NHS dm+d

MHRA licensed products

View all licensed products for Arginine on the MHRA register

Arginine 2g/5ml oral solution

Drug Tariff Special Order

None

Special

Source: NHS dm+dOGL 3.0

Updated about 1 month ago(1 Mar 2026)

PriceShow details

£0.16indicative price

This is the NHS Drug Tariff indicative price used for reimbursement purposes. It may not reflect the price paid by patients or pharmacies.

View full Drug Tariff

Source: NHS Drug Tariff via NHSBSA. Derived from dm+d VMPP (Virtual Medicinal Product Pack) pricing data. Contains public sector information licensed under the Open Government Licence v3.0.

Therapeutically similar medicines

10 similarShow details

Arginine 500mg/5ml oral solution sugar free

Oral solution

500mg/5ml

Same therapeutic group

Arginine 1g tablets

Tablet

Same therapeutic group

Arginine 500mg tablets

Tablet

500mg

Same therapeutic group

Arginine 1.5mg/5ml oral solution

Oral solution

1.5mg/5ml

Same therapeutic group

Arginine 500mg capsules

Capsule

500mg

Same therapeutic group

Similarity based on WHO Anatomical Therapeutic Chemical (ATC) classification and NHS BNF section grouping. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.

NHS prescribing volume and spending trends

Show details

Loading prescribing data...

Clinical guidelines and formulary information

British National Formulary

Arginine

BNF

Drug monograph — bnf.nice.org.uk

Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.

NICE clinical guidance(3)

Pegzilarginase for treating arginase-1 deficiency in people 2 years and over (HST35)

HST35

Highly specialised technology

Updated Mar 2026

DuraGraft for preserving vascular grafts (MIB184)

MIB184

Guidance

Updated May 2019

Macimorelin for diagnosing growth hormone deficiency (MIB320)

MIB320

Guidance

Updated Mar 2023

Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.

Check stock at pharmacies and supply information

Show details

Pharmacy stock checkers

Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.

Boots

Search products

Click & collectNHS

Lloyds

Search products

DeliveryNHS

P2U

Pharmacy2U

Search products

DeliveryNHS

Supply & product information

Official product databases and supply status monitoring

Shortages info

NHS Specialist Pharmacy Service (SPS)

emc product search

Discontinuations & alternatives for Arginine

Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.

Codes for healthcare professionals and prescribing systems

Show details

These codes are used by healthcare IT systems and prescribers to identify this medicine.

NHS UK identifiers

SNOMED CT

8278711000001106

dm+d ID

8278711000001106

VTM (Virtual Therapeutic Moiety)

9900511000001105

VMP (Virtual Medicinal Product)

8278711000001106

BNF code

09110100

International identifiers

ATC code — Anatomical Therapeutic Chemical (WHO)

A05BA01

Browse tools

dm+d Browser

NHSBSA medicines dictionary lookup

SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA). ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).

Active and completed clinical studies from ClinicalTrials.gov

Show details

Searching UK clinical trials...

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.

Pharmacology and chemical data from DrugBank

go.drugbank.com

Key facts

Drug status

Approved

Major interactions

None known

Half-life

Not available

Mechanism

Many of supplemental L-arginine's activities, including its possible anti-athero…

Food interactions

None known

Human targets

10 targets

Data: DrugBank · CC BY-NC 4.0

Pharmacokinetics at a glance

Absorption

Absorbed from the lumen of the small intestine into the enterocytes. Absorption is efficient and occurs by an active transport mechanism.

Metabolism

Some metabolism of L-arginine takes place in the enterocytes.…

Pharmacokinetic data: DrugBank · CC BY-NC 4.0

Status:

Approved

Investigational

Nutraceutical

Small molecule

About this compound

An essential amino acid that is physiologically active in the L-form.

Properties:

solid

Avg. mass: 174.20 Da

DrugBank indication

Used for nutritional supplementation, also for treating dietary shortage or imbalance.

Also known as(83)

(2S)-2-amino-5-(carbamimidamido)pentanoic acid

(2S)-2-amino-5-guanidinopentanoic acid

(S)-2-amino-5-guanidinopentanoic acid

(S)-2-Amino-5-guanidinovaleric acid

2-amino-5-guanidino-pentanoic acid

Arg

Arginina

Arginine

Dosage forms(56)

Capsule (Oral)

Solution (Parenteral)

Powder (Oral)

Solution (Intravenous) — 10.50 g/1000ml

Injection (Intravenous) — 0.5 g/l

Injection (Intravenous) — 0.25 g/1000ml

Solution, concentrate (Intravenous)

Injection (Intravenous) — 0.52 g/l

Molecular properties(19)

Toxicity & overdose

Oral supplementation with L-arginine at doses up to 15 grams daily are generally well tolerated. The most common adverse reactions of higher doses from 15 to 30 grams daily are nausea, abdominal cramps and diarrhea. Some may experience these symptoms at lower doses.

How it works

Mechanism of action

Many of supplemental L-arginine's activities, including its possible anti-atherogenic actions, may be accounted for by its role as the precursor to nitric oxide or NO. NO is produced by all tissues of the body and plays very important roles in the cardiovascular system, immune system and nervous system. NO is formed from L-arginine via the enzyme nitric oxide synthase or synthetase (NOS), and the effects of NO are mainly mediated by 3,'5' -cyclic guanylate or cyclic GMP. NO activates the enzyme guanylate cyclase, which catalyzes the synthesis of cyclic GMP from guanosine triphosphate or GTP. Cyclic GMP is converted to guanylic acid via the enzyme cyclic GMP phosphodiesterase. NOS is a heme-containing enzyme with some sequences similar to cytochrome P-450 reductase. Several isoforms of NOS exist, two of which are constitutive and one of which is inducible by immunological stimuli. The constitutive NOS found in the vascular endothelium is designated eNOS and that present in the brain, spinal cord and peripheral nervous system is designated nNOS. The form of NOS induced by immunological or inflammatory stimuli is known as iNOS. iNOS may be expressed constitutively in select tissues such as lung epithelium. All the nitric oxide synthases use NADPH (reduced nicotinamide adenine dinucleotide phosphate) and oxygen (O2) as cosubstrates, as well as the cofactors FAD (flavin adenine dinucleotide), FMN (flavin mononucleotide), tetrahydrobiopterin and heme. Interestingly, ascorbic acid appears to enhance NOS activity by increasing intracellular tetrahydrobiopterin. eNOS and nNOS synthesize NO in response to an increased concentration of calcium ions or in some cases in response to calcium-independent stimuli, such as shear stress. In vitro studies of NOS indicate that the Km of the enzyme for L-arginine is in the micromolar range. The concentration of L-arginine in endothelial cells, as well as in other cells, and in plasma is in the millimolar range. What this means is that, under physiological conditions, NOS is saturated with its L-arginine substrate. In other words, L-arginine would not be expected to be rate-limiting for the enzyme, and it would not appear that supraphysiological levels of L-arginine which could occur with oral supplementation of the amino acid^would make any difference with regard to NO production. The reaction would appear to have reached its maximum level. However, in vivo studies have demonstrated that, under certain conditions, e.g. hypercholesterolemia, supplemental L-arginine could enhance endothelial-dependent vasodilation and NO production.

Pharmacodynamics

Studies have shown that is has improved immune responses to bacteria, viruses and tumor cells; promotes wound healing and regeneration of the liver; causes the release of growth hormones; considered crucial for optimal muscle growth and tissue repair.

Pharmacokinetics

How the body processes this drug — absorption, distribution, metabolism, and elimination

Absorption

Absorbed from the lumen of the small intestine into the enterocytes. Absorption is efficient and occurs by an active transport mechanism.

Metabolism

Some metabolism of L-arginine takes place in the enterocytes. L-arginine not metabolized in the enterocytes enters the portal circulation from whence it is transported to the liver, where again some portion of the amino acid is metabolized.

Drug targets(10)

Proteins and enzymes this drug interacts with in the body

Cationic amino acid transporter 3

BE0000136

SLC7A3

Specific functionamino acid transmembrane transporter activity

Cellular location

Cell membrane

General function & pharmacology

Uniporter that mediates the uptake of cationic L-amino acids such as L-arginine, L-lysine and L-ornithine .
PMID:11591158
The transport is sodium ions- and pH-independent, moderately trans-stimulated and is mediated by passive diffusion PMID:11591158

Thymidine kinase, cytosolic

BE0001260

TK1

modulator

Specific functionATP binding

Cellular location

Cytoplasm

General function & pharmacology

Cell-cycle-regulated enzyme of importance in nucleotide metabolism .
PMID:9575153
Catalyzes the first enzymatic step in the salvage pathway converting thymidine into thymidine monophosphate .
PMID:22385435
Transcriptional regulation limits expression to the S phase of the cell cycle and transient expression coincides with the oscillation in the intracellular dTTP concentration (Probable). Also important for the activation of anticancer and antiviral nucleoside analog prodrugs such as 1-b-d-arabinofuranosylcytosine (AraC) and 3c-azido-3c-deoxythymidine (AZT) PMID:22385435

Antizyme inhibitor 2

BE0000448

AZIN2

Specific functionarginine decarboxylase activity

Cellular location

Nucleus

General function & pharmacology

Antizyme inhibitor (AZI) protein that positively regulates ornithine decarboxylase (ODC) activity and polyamine uptake. AZI is an enzymatically inactive ODC homolog that counteracts the negative effect of ODC antizymes (AZs) OAZ1, OAZ2 and OAZ3 on ODC activity by competing with ODC for antizyme-binding .
PMID:17900240
Inhibits antizyme-dependent ODC degradation and releases ODC monomers from their inactive complex with antizymes, leading to formation of the catalytically active ODC homodimer and restoring polyamine production .
PMID:17900240
Participates in the morphological integrity of the trans-Golgi network (TGN) and functions as a regulator of intracellular secretory vesicle trafficking PMID:20188728

Argininosuccinate lyase

BE0000520

ASL

Specific functionargininosuccinate lyase activity

General function & pharmacology

Catalyzes the reversible cleavage of L-argininosuccinate to fumarate and L-arginine, an intermediate step reaction in the urea cycle mostly providing for hepatic nitrogen detoxification into excretable urea as well as de novo L-arginine synthesis in nonhepatic tissues .
PMID:11747432 PMID:11747433 PMID:22081021 PMID:2263616 PMID:9045711

Essential regulator of intracellular and extracellular L-arginine pools. As part of citrulline-nitric oxide cycle, forms tissue-specific multiprotein complexes with argininosuccinate synthase ASS1, transport protein SLC7A1 and nitric oxide synthase NOS1, NOS2 or NOS3, allowing for cell-autonomous L-arginine synthesis while channeling extracellular L-arginine to nitric oxide synthesis pathway PMID:22081021

Nitric oxide synthase, inducible

BE0000005

NOS2

Specific functionarginine binding

Cellular location

Cytoplasm, cytosol

General function & pharmacology

Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body .
PMID:7504305 PMID:7531687 PMID:7544004 PMID:7682706

In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such PTGS2/COX2 (By similarity). As component of the iNOS-S100A8/9 transnitrosylase complex involved in the selective inflammatory stimulus-dependent S-nitrosylation of GAPDH on 'Cys-247' implicated in regulation of the GAIT complex activity and probably multiple targets including ANXA5, EZR, MSN and VIM .
PMID:25417112
Involved in inflammation, enhances the synthesis of pro-inflammatory mediators such as IL6 and IL8 PMID:19688109

Transporters(3)

Proteins that transport this drug across cell membranes

Organic cation/carnitine transporter 2

BE0000106

SLC22A5

inhibitor

Specific function(R)-carnitine transmembrane transporter activity

Cellular location

Cell membrane

General function & pharmacology

Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine .
PMID:10454528 PMID:10525100 PMID:10966938 PMID:17509700 PMID:20722056 PMID:33124720

Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium.

Relative uptake activity ratio of carnitine to TEA is 11.3 .
PMID:10454528 PMID:10525100 PMID:10966938

In intestinal epithelia, transports the quorum-sensing pentapeptide CSF (competence and sporulation factor) from B.subtilis which induces cytoprotective heat shock proteins contributing to intestinal homeostasis .
PMID:18005709
May also contribute to regulate the transport of organic compounds in testis across the blood-testis-barrier (Probable)

Monocarboxylate transporter 10

BE0003654

SLC16A10

inhibitor

Specific functionamino acid transmembrane transporter activity

Cellular location

Cell membrane

General function & pharmacology

Sodium- and proton-independent thyroid hormones and aromatic acids transporter .
PMID:11827462 PMID:18337592 PMID:28754537

Mediates both uptake and efflux of 3,5,3'-triiodothyronine (T3) and 3,5,3',5'-tetraiodothyronine (T4) with high affinity, suggesting a role in the homeostasis of thyroid hormone levels .
PMID:18337592
Responsible for low affinity bidirectional transport of the aromatic amino acids, such as phenylalanine, tyrosine, tryptophan and L-3,4-dihydroxyphenylalanine (L-dopa) .
PMID:11827462 PMID:28754537
Plays an important role in homeostasis of aromatic amino acids (By similarity)

Solute carrier family 22 member 4

BE0000757

SLC22A4

inhibitor

Specific functionacetylcholine transmembrane transporter activity

Cellular location

Apical cell membrane

General function & pharmacology

Transporter that mediates the transport of endogenous and microbial zwitterions and organic cations .
PMID:10215651 PMID:15107849 PMID:15795384 PMID:16729965 PMID:20601551 PMID:22206629 PMID:22569296 PMID:29530864

Functions as a Na(+)-dependent and pH-dependent high affinity microbial symporter of potent food-derived antioxidant ergothioeine .
PMID:15795384 PMID:29530864 PMID:33124720

Transports one sodium ion with one ergothioeine molecule (By similarity). Involved in the absorption of ergothioneine from the luminal/apical side of the small intestine and renal tubular cells, and into non-parenchymal liver cells, thereby contributing to maintain steady-state ergothioneine level in the body .
PMID:20601551
Also mediates the bidirectional transport of acetycholine, although the exact transport mechanism has not been fully identified yet .
PMID:22206629
Most likely exports anti-inflammatory acetylcholine in non-neuronal tissues, thereby contributing to the non-neuronal cholinergic system .
PMID:22206629 PMID:22569296
Displays a general physiological role linked to better survival by controlling inflammation and oxidative stress, which may be related to ergothioneine and acetycholine transports .
PMID:15795384 PMID:22206629
May also function as a low-affinity Na(+)-dependent transporter of L-carnitine through the mitochondrial membrane, thereby maintaining intracellular carnitine homeostasis .
PMID:10215651 PMID:15107849 PMID:16729965

May contribute to regulate the transport of cationic compounds in testis across the blood-testis-barrier PMID:35307651

Biological pathways(30)

Citrullinemia Type I

disease

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Calcium,Pyrophosphoric acid,Alanine,Arginine,Aspartic acid,Citrulline,Glutamic acid,L-Glutamine,Ornithine,Maleic acid,NADH,Pyridoxal phosphate,Pyruvic acid,Urea

Carbamoyl Phosphate Synthetase Deficiency

disease

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Calcium,Pyrophosphoric acid,Alanine,Arginine,Aspartic acid,Citrulline,Glutamic acid,L-Glutamine,Ornithine,Maleic acid,NADH,Pyridoxal phosphate,Pyruvic acid,Urea

Argininosuccinic Aciduria

disease

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Calcium,Pyrophosphoric acid,Alanine,Arginine,Aspartic acid,Citrulline,Glutamic acid,L-Glutamine,Ornithine,Maleic acid,NADH,Pyridoxal phosphate,Pyruvic acid,Urea

Urea Cycle

metabolic

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Calcium,Pyrophosphoric acid,Alanine,Arginine,Aspartic acid,Citrulline,Glutamic acid,L-Glutamine,Ornithine,Maleic acid,NADH,Pyridoxal phosphate,Pyruvic acid,Urea

Ornithine Transcarbamylase Deficiency (OTC Deficiency)

disease

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Calcium,Pyrophosphoric acid,Alanine,Arginine,Aspartic acid,Citrulline,Glutamic acid,L-Glutamine,Ornithine,Maleic acid,NADH,Pyridoxal phosphate,Pyruvic acid,Urea

Argininemia

disease

Involved compounds

Oxogluric acid,Adenosine phosphate,ATP,Calcium,Pyrophosphoric acid,Alanine,Arginine,Aspartic acid,Citrulline,Glutamic acid,L-Glutamine,Ornithine,Maleic acid,NADH,Pyridoxal phosphate,Pyruvic acid,Urea

Nitric Oxide Signaling Pathway

signaling

Involved compounds

Calcium,Flavin adenine dinucleotide,Arginine,Citrulline,Mesoheme,Nitric Oxide,Flavin mononucleotide,Sapropterin

Scientific references(3)

Morris SM Jr

Enzymes of Arginine Metabolism.

The Journal of Nutrition

2004134(10):2743S-2747S. doi: 10.1093/jn/134.10.2743s

PMID: 15465778 DOI: 10.1093/jn/134.10.2743s

Schulman S.P., Becker L.C., Kass D.A., Champion H.C., Terrin M.L., Forman S., Ernst K.V., Kelemen M.D., Townsend S.N., Capriotti A., Hare J.M., Gerstenblith G.

L-Arginine Therapy in Acute Myocardial Infarction.

Journal of the American Medical Association

2006295(1):58. doi: 10.1001/jama.295.1.58

PMID: 16391217 DOI: 10.1001/jama.295.1.58

Alba-Roth J., Muller O.A., Schopohl J., von Werder K.

Arginine Stimulates Growth Hormone Secretion by Suppressing Endogenous Somatostatin Secretion*.

The Journal of Clinical Endocrinology & Metabolism

198867(6):1186-1189. doi: 10.1210/jcem-67-6-1186

PMID: 2903866 DOI: 10.1210/jcem-67-6-1186

ATC classification(2 codes)

ATC V03AF11

ATC B05XB01

Affected organisms(1)

Humans and other mammals

International brands(1)

Salt forms(2)

Arginine butyrate(DBSALT003350)

Arginine hydrochloride(DBSALT000869)

Experimental properties(4)

External resources(2)

PDRhealth Drugs.com

Commercial products(173)

Chemical identifiers

CAS, UNII, InChI Key and database cross-references

Show

Linked compound data from DrugBank Open Data (CC BY-NC 4.0)

Arginine

DB00125

CAS number

74-79-3

UNII (FDA)

94ZLA3W45F

InChI Key (molecular fingerprint)

ODKSFYDXXFIFQN-BYPYZUCNSA-N

Additional database identifiers

Drugs Product Database (DPD)

938

Drugs Product Database (DPD)

13800

Drugs Product Database (DPD)

10242

ChEBI

16467

PubChem Compound

6322

PubChem Substance

46507180

KEGG Compound

C00062

KEGG Drug

D02982

ChemSpider

6082

BindingDB

181132

PharmGKB

PA448478

PDB

ARG

IUPHAR

721

Guide to Pharmacology

721

Wikipedia

Arginine

ChEMBL

CHEMBL1485

ZINC

ZINC000001532525

RxCUI

1091

HUGO Gene Nomenclature Committee (HGNC)

HGNC:11061

GenAtlas

SLC7A3

GeneCards

SLC7A3

GenBank Gene Database

AF320612

GenBank Protein Database

17224957

UniProtKB

Q8WY07

UniProt Accession

CTR3_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:11830

GenAtlas

TK1

GeneCards

TK1

GenBank Gene Database

K02581

GenBank Protein Database

339709

UniProtKB

P04183

UniProt Accession

KITH_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:29957

GenAtlas

ADC

GeneCards

AZIN2

GenBank Gene Database

AY050634

GenBank Protein Database

15858863

UniProtKB

Q96A70

UniProt Accession

AZIN2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:746

GenAtlas

ASL

GeneCards

ASL

GenBank Gene Database

Y00753

GenBank Protein Database

28878

UniProtKB

P04424

UniProt Accession

ARLY_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:7873

GenAtlas

NOS2A

GeneCards

NOS2

GenBank Gene Database

L09210

GenBank Protein Database

292242

Guide to Pharmacology

1250

UniProtKB

P35228

UniProt Accession

NOS2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:11057

GenAtlas

SLC7A1

GeneCards

SLC7A1

GenBank Gene Database

X59155

GenBank Protein Database

36161

UniProtKB

P30825

UniProt Accession

CTR1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:664

GenAtlas

ARG2

GeneCards

ARG2

GenBank Gene Database

D86724

GenBank Protein Database

1694633

Guide to Pharmacology

1245

UniProtKB

P78540

UniProt Accession

ARGI2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:11062

GenAtlas

SLC7A4

GeneCards

SLC7A4

GenBank Gene Database

AJ000730

GenBank Protein Database

4378940

UniProtKB

O43246

UniProt Accession

CTR4_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:758

GenAtlas

ASS1

GeneCards

ASS1

GenBank Gene Database

X01630

GenBank Protein Database

28872

UniProtKB

P00966

UniProt Accession

ASSY_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:7876

GenAtlas

NOS3

GeneCards

NOS3

GenBank Gene Database

M93718

GenBank Protein Database

189212

Guide to Pharmacology

1249

UniProtKB

P29474

UniProt Accession

NOS3_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:10969

GenAtlas

SLC22A5

GeneCards

SLC22A5

GenBank Gene Database

AF057164

GenBank Protein Database

3273741

UniProtKB

O76082

UniProt Accession

S22A5_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:17027

GeneCards

SLC16A10

GenBank Gene Database

AB057445

GenBank Protein Database

18640047

UniProtKB

Q8TF71

UniProt Accession

MOT10_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:10968

GenAtlas

SLC22A4

GeneCards

SLC22A4

GenBank Gene Database

AB007448

GenBank Protein Database

2605501

UniProtKB

Q9H015

UniProt Accession

S22A4_HUMAN

International reference pricing

6 formulations

Reference pricing from DrugBank. Prices are indicative and may not reflect current UK costs.

From $0.04/ml

To $0.51/g

R-gene 10 vial

$0.04/ml

L-arginine 1000 mg tablet

$0.07/tablet

Arginine 500 mg tablet

$0.09/tablet

Arginine-500 mg tablet

$0.12/tablet

L-arginine mhc powder

$0.39/g

Source: DrugBank. Used under CC BY-NC 4.0 academic licence for non-commercial purposes.

Patent information

1 active patent

12390398

United States

Approved 3 May 2016 · Expires 3 May 2036

10y 1m

Source: DrugBank · CC BY-NC 4.0. Patent data sourced from national patent offices. Expiry dates may not reflect extensions, regulatory exclusivity periods, or legal challenges.

DrugBank citations

If you use DrugBank data in your research, please cite the following publications:

Knox C., Wilson M., Klinger C.M., et al

DrugBank 6.

0: the DrugBank Knowledgebase for 2024

Nucleic Acids Res. 2024 Jan 552(D1):D1265-D1275

PMID: 37953279

Wishart D.S., Feunang Y.D., Guo A.C., et al

DrugBank 5.

0: a major update to the DrugBank database for 2018

Nucleic Acids Res. 2017 Nov 846(D1):D1074-D1082

PMID: 29126136

Show earlier publications

Law V., Knox C., Djoumbou Y., et al

DrugBank 4.

0: shedding new light on drug metabolism

Nucleic Acids Res. 2014 Jan 142(1):D1091-7

PMID: 24203711

Knox C., Law V., Jewison T., et al

DrugBank 3.

0: a comprehensive resource for 'omics' research on drugs

Nucleic Acids Res. 2011 Jan39(Database issue):D1035-41

PMID: 21059682

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a knowledgebase for drugs, drug actions and drug targets.

Nucleic Acids Research

2008 Jan36(Database issue):D901-6

PMID: 18048412

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Nucleic Acids Research

2006 Jan 134(Database issue):D668-72

PMID: 16381955

Source: go.drugbank.comCC BY-NC 4.0

Updated 27 days ago(8 Mar 2026)

Back to medicines

Arginine 2g/5ml oral solution

Official medicine documents

Safety monitoring data

Yellow Card reports

EudraVigilance

British National Formulary

NICE clinical guidance(3)

Pharmacy stock checkers

Supply & product information

NHS UK identifiers

International identifiers

Browse tools

Key facts

Pharmacokinetics at a glance

Absorption

Metabolism

Clinical essentials

Pharmacology

Deep science
43

Chemical identifiers

Arginine

Additional database identifiers

International reference pricing

Patent information

DrugBank citations

Arginine 2g/5ml oral solution

Safety & regulatory

Official medicine documents

Safety monitoring data

Yellow Card reports

EudraVigilance

Brand versions and licensed products

NHS reimbursement price

Medicines like this

Prescribing statistics

Guidance (NICE / BNF)

British National Formulary

NICE clinical guidance(3)

Availability, stocks & shortages

Pharmacy stock checkers

Supply & product information

Professional identifiers

NHS UK identifiers

International identifiers

Browse tools

Clinical trials

DrugBank data

Key facts

Pharmacokinetics at a glance

Absorption

Metabolism

Clinical essentials

Pharmacology

Deep science43

Chemical identifiers

Arginine

Additional database identifiers

International reference pricing

Patent information

DrugBank citations

Deep science
43